Monomeric Peptide Multi-agonist Targeting the GLP1 Receptor and NPY Receptors

Keyphrases

• NPY Receptors 100%
• Dual Agonism 50%
• Once-daily Administration 50%
• Neuropeptide Y Receptor 50%
• Inflammatory Damage 50%
• β-islets 50%

Biochemistry, Genetics and Molecular Biology

• Neuropeptide Y Receptor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Neuropeptide Y Receptor 33%